Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2025 10:35 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando

CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today...
September 17, 2025 07:02 ET | Source: EyeMD EMR Healthcare Systems, LLC

EyeMD EMR Healthcare Systems Announces Rebrand to Optivate, Signaling Expanded Vision for Ophthalmology Practices and Eye Care Providers

EyeMD EMR Healthcare Systems Announces Rebrand to Optivate, Signaling Expanded Vision for Ophthalmology Practices and Eye Care Providers
October 23, 2024 09:00 ET | Source: Alkeus Pharmaceuticals

Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement

Alkeus Pharmaceuticals, Inc., today announced that results from its study of gildeuretinol in geographic atrophy were presented at AAO 2024.
October 22, 2024 07:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

- CLS-AX Phase 3 Ready Based on Positive Phase 2b Topline Data in Wet AMD - - Differentiated Profile for CLS-AX Targeting Flexible Dosing Similar to a Biologic with the Potential Extended Duration of...
October 17, 2024 08:29 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Announces Data Presentations at the American Academy of Ophthalmology (AAO) 2024 Annual Meeting, October 18-21 in Chicago

Results from Study of Oral Gildeuretinol for Geographic Atrophy Secondary to Age-Related Macular Degeneration to be Presented as Late-Breaker During Retina Subspecialty Day Positive Data from TEASE...
November 07, 2023 16:20 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting

ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
November 02, 2023 07:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting

Clearside Biomedical announced that multiple oral & poster presentations will be delivered at the American Academy of Ophthalmology (AAO) 2023 Annual Mtg.
October 31, 2023 09:55 ET | Source: EyeMD EMR Healthcare Systems, Inc.

EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023

EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023
October 30, 2023 10:42 ET | Source: Nextech Systems, Inc.

Nextech to Highlight Ophthalmology Solution Innovations at AAO Conference

Nextech will showcase transformative innovations to its ophthalmology industry-leading software at the AAO 2023 conference from Nov. 3-6.
October 16, 2023 08:00 ET | Source: Iantrek, Inc.

Iantrek reports two upcoming American Academy of Ophthalmology presentations of its breakthrough glaucoma surgical technologies, including 1-year results of a novel supraciliary outflow micro-interventional procedure

Biotech startup to present 12 month data for novel Glaucoma treatment at AAO.